AI in Blood Pressure Monitoring Market Report 2026

The artificial intelligence (AI) in blood pressure monitoring market size has grown exponentially in recent years. It will grow from $1.39 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 27%. The growth in the historic period can be attributed to increasing prevalence of hypertension, growing adoption of digital health tools, rising awareness of home monitoring, expanding use of wearable sensors, and increasing healthcare expenditure.

The artificial intelligence (AI) in blood pressure monitoring market size is expected to see exponential growth in the next few years. It will grow to $4.54billion in 2030 at a compound annual growth rate (CAGR) of 26.7%. The growth in the forecast period can be attributed to growing demand for continuous monitoring, rising integration of artificial intelligence (AI)-powered diagnostics, expanding telehealth penetration, increasing focus on preventive healthcare, and growing investment in medical artificial intelligence. Major trends in the forecast period include technology advancements in sensor accuracy, innovations in artificial intelligence (AI)-driven predictive analytics, developments in cuffless monitoring solutions, research and development in multimodal biometrics, and advancements in cloud-based health data platforms.

The rising prevalence of hypertension is expected to propel the growth of artificial intelligence (AI) in the blood pressure monitoring market going forward. Hypertension is a chronic medical condition characterized by persistently elevated blood pressure levels, increasing the risk of cardiovascular diseases, stroke, and kidney disorders, and often requiring lifelong monitoring and management. The incidence of hypertension is increasing due to factors such as unhealthy diets high in salt and fat, physical inactivity, obesity, stress, and an aging population, leading to a growing number of patients requiring regular and accurate blood pressure assessment. AI-powered blood pressure monitoring solutions support hypertension management by enabling continuous or real-time monitoring, predictive analytics, and personalized alerts that help detect abnormal patterns early and support timely clinical interventions. For instance, in March 2025, according to the U.S. National Center for Biotechnology Information (NCBI), a US-based government research center, the age-adjusted prevalence of hypertension among adults rose to 27.5% in 2023 from 27.2% in 2022, reflecting a steady increase in high blood pressure cases. Therefore, the rising prevalence of hypertension is driving the adoption and growth of artificial intelligence (AI) in the blood pressure monitoring market.

Key players operating in the AI in blood pressure monitoring market are focusing on developing innovative solutions, such as hemodynamic monitoring platforms, to gain a competitive advantage. Hemodynamic monitoring platforms refer to systems and devices that continuously measure and assess blood flow, blood pressure, and cardiac output within the cardiovascular system to guide patient management and treatment decisions. For instance, in April 2025, BD, a US-based medical technology company, launched the Hemosphere Alta advanced hemodynamic monitoring platform, featuring the cerebral autoregulation index for personalized blood flow assessment, the Acumen hypotension prediction index for early warning of blood pressure drops, and a high-resolution touchscreen with voice and gesture controls for improved usability. The platform also supports seamless integration with electronic health record systems, enabling comprehensive patient data management.

In April 2024, Omron Healthcare, a Japan-based leading company in home health monitoring equipment and digital health solutions, acquired Luscii Healthtech B.V. for an undisclosed amount. With this acquisition, Omron Healthcare aimed to enhance its AI-driven remote patient and blood pressure monitoring capabilities and accelerate digital care adoption across primary and specialist care environments. Luscii Healthtech B.V. is a Netherlands-based provider of a customizable remote patient monitoring platform that uses AI-powered clinical engines to track and interpret vital signs.

Major companies operating in the artificial intelligence (AI) in blood pressure monitoring market are Apple Inc., Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., Masimo Corporation, Shen AI, Omron Healthcare Inc., A&D Company Limited, Valencell Inc., Binah.ai Ltd., Lifelight.AI, BioIntelliSense Inc., Nanowear Inc., FaceHeart Corporation, Hilo Group GmbH, Vastmindz AI Ltd., Biospectal SA, Briah.ai, Biobeat Technologies, Biozen LLC, Dynocardia Inc., Sensifree Co. Ltd.

North America was the largest region in the artificial intelligence (AI) in blood pressure monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in blood pressure monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) in blood pressure monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the ai in blood pressure monitoring market by increasing the cost of importing advanced sensors, wearable devices, and cloud infrastructure components, particularly affecting segments like smart cuffs and wearable devices in regions such as north america and europe. these costs have led to slower adoption in certain healthcare facilities and delayed product launches. however, tariffs have also encouraged local manufacturing and innovation, allowing some companies to develop cost-efficient, domestically produced ai monitoring solutions.

Artificial intelligence (AI) in blood pressure monitoring involves the use of advanced algorithms and data-driven models to automatically collect, analyze, and interpret readings from connected monitoring devices, generating actionable clinical insights. This technology aims to enable early detection of hypertension-related risks, support personalized treatment decisions, and enhance long-term cardiovascular health management through continuous and accurate monitoring.

The primary product types in artificial intelligence-based blood pressure monitoring include wearable devices, smart cuffs, mobile applications, and standalone AI systems. Wearable devices are connected tools that continuously record blood pressure and apply AI algorithms to detect patterns, trends, and risk indicators. Deployment models include on-device AI, cloud-based AI, and hybrid AI systems. Supporting technologies include machine learning, natural language processing, and computer vision techniques. Applications involve continuous monitoring, diagnostic assistance, remote patient management, and clinical decision support, serving hospitals, home healthcare, ambulatory care centers, and specialty clinics.

The artificial intelligence (AI) in blood pressure monitoring market consists of revenues earned by entities by providing services such as real-time blood pressure analytics, predictive hypertension risk assessment, remote patient monitoring, clinical decision support, and data integration with electronic health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in blood pressure monitoring market also includes sales of artificial intelligence (AI)-enabled blood pressure monitors, wearable blood pressure devices, smart cuffs, mobile health applications, and cloud-based monitoring platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.